Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity. Wallace DK, Hercinovic A, Freedman SF, Crouch ER, et al. J AAPOS 2023 Jan 18:S1091-8531(23)00011-3. doi: 10.1016/j.jaapos.2022.

Read + Share

Amedeo Smart

Independent Medical Education

Wallace DK, Hercinovic A, Freedman SF, Crouch ER, et al. Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity. J AAPOS 2023 Jan 18:S1091-8531(23)00011-3. doi: 10.1016/j.jaapos.2022.
PMID: 36681111